Thumbnail
Pepvax logo 20small

PepVax, Inc.

Immunotherapy Revolutionized

  • Stage Product In Development
  • Industry Biotechnology
  • Location Bethesda, MD, USA
  • Currency USD
  • Founded February 2013
  • Employees 4
  • Incorporation Type C-corp
  • Website pepvax.co

Company Summary

PepVax, Inc. is a virtual biotechnology company whose foremost goal is to develop therapeutics for cancer through the rapid and efficient development of cutting edge peptide vaccine candidates using bioinformatics and outsourced laboratory resources.

Team

  • Dsc 2759
    President and CEO

    Biotechnology entrepreneur with extensive experience in the healthcare and life sciences industry. He has a Master's in Biotechnology from University of Pennsylvania with experience in business development, consulting for start-ups, as well as research in academia and pharmaceutical industry focusing on antibiotics and vaccines.

  • Default avatar
    Anton Dormer
    Chairman and Chief Scientific Officer

    Biotechnology entrepreneur with extensive experience in the healthcare and life sciences industry. He has a Master's in Biotechnology from University of Pennsylvania with experience in business development, consulting for start-ups, as well as research in academia and pharmaceutical industry focusing on antibiotics and vaccines.

  • F20c4dc4 b4c4 4aec 84fe cd2e46898cc6
    VP, Bioinformatics

    Dr. Daniel Achinko is a research scientist at the University of Yaounde I (UYI), Cameroon. He received his doctorate in Bioinformatics with a focus on Co-parasitic infections, and a Master's in Molecular Parasitology with focus on genotyping the Plasmodium strains of malaria. He is currently a member of the East African Bioinformatic group and the International Society of Computational Biology.

Advisors

  • Default avatar
    Sherman Rogers
    Lawyer
    Unconfirmed
    Default avatar
    Elton Norman
    Accountant
    Unconfirmed
    Fc8b93ff bd43 4eed a0e3 b342b4ebb15c
    Patent Lawyer, Scientific Board Advisor
  • 7d4d404b 5ab9 49d3 b146 1bc83700b371
    Scientific Advisory Board